Evaluating the efficacy and safety of TXA therapy in aSAH patients.

Aneurysm subarachnoid hemorrhage (aSAH) accounts for 5% of all strokes and has an incidence of 7.9 per 100,000 personyears

Copyright © 2020 Terumo India Private limited

Important information regarding

By using this website, you consent to the use of cookies in accordance with our